Background {#Sec1}
==========

The occurrence of stroke during cardiac surgery is a complication associated with a poor in-hospital and long-term prognosis \[[@CR1]\]. The incidence of carotid artery stenosis concurrent with coronary artery disease varies between 2 and 22% and it is preoperatively found in up to 8% of patients undergoing CABG \[[@CR2]--[@CR5]\]. The treatment of the asymptomatic carotid stenosis before CABG was shown to reduce stroke \[[@CR6]\]. However, the guidelines recommend carotid revascularization prior to cardiac surgery only for symptomatic and bilateral carotid stenosis \> 70--80% \[[@CR7], [@CR8]\]. The cut-off stenosis grade justifying the CEA indication for the asymptomatic, unilateral stenosis, and the ideal timing of the carotid revascularization (staged or simultaneous with CABG) are not well established. Our study aimed to compare the outcomes of patients with unilateral asymptomatic carotid stenosis ≥60%, who received CEA before CABG as a simultaneous or a staged procedure, to those with untreated carotid stenosis.

Methods {#Sec2}
=======

Institutional protocol {#Sec3}
----------------------

All patients referred to CABG in our institution were screened for carotid artery stenosis with duplex sonography. Our center's protocol included the treatment of an asymptomatic carotid artery stenosis before CABG at a stenosis grade ≥ 70% and depending on the assessment of the attending surgeon. Thus, in the time period between 2004 and 2016, 15 asymptomatic patients with a 60--69% stenosis, 40 patients with a 70--79% stenosis and 13 patients with a stenosis grade ≥ 80% have not been treated by CEA before CABG and served as a control group in this study (no-CEA group). The cut-off stenosis value in the control group was chosen according to the national and international guidelines for isolated carotid artery disease, which recommend the treatment of asymptomatic stenosis ≥60% \[[@CR9], [@CR10]\].

In the past years, two different revascularization strategies were pursued in the management of unilateral asymptomatic carotid artery stenosis prior to CABG procedures. From 2004 to 2012 simultaneous (CEA + CABG) procedure in general anesthesia was performed, and since 2012 staged approach in local anesthesia was favorized. Patients with unilateral carotid stenosis ≥60% and isolated CABG were identified throughout the study period and mainly between 2010 and 2014 (45; 66%).

Staged procedure {#Sec4}
----------------

During the same hospital stay CEA was performed before CABG under local anesthesia (with ultrasound-guided combined superficial and deep cervical plexus block) and near-infrared spectroscopy surveillance (INVOS™, Medtronic, Minneapolis, U.S.A.). Carotid shunting was performed only in patients with obvious clamping ischemia (selective shunting). The carotid reconstruction was performed either as a patch thrombendarterectomy or eversion endarterectomy. Postoperatively, all patients were neurologically examined by the anesthesiologists and the surgical team. The success of the carotid revascularization was additionally evaluated by duplex sonography performed by the neurologists before discharge in the simultaneous CEA group and before CABG in the staged CEA group. The CABG procedure was performed after 4 days in median.

Simultaneous procedure {#Sec5}
----------------------

The CEA was performed simultaneously with cardiac surgery under general anesthesia before the initiation of cardiopulmonary bypass. Routine shunting was conducted and neuro-monitoring was performed by near-infrared spectroscopy (INVOS™, Medtronic, Minneapolis, U.S.A.) during the entire procedure. The carotid reconstruction was performed as a patch thrombendarteriectomy. The patients were neurologically evaluated after extubation by the intensive care physicians and the surgical team.

Data acquisition {#Sec6}
----------------

Data were acquired from the medical records: 1219 CEA procedures were performed from 2004 to 2017 at our center, while CEA and CABG were conducted in 206 cases during the same hospital stay.

Exclusion criteria were contralateral stenoses ≥60% or contralateral carotid occlusion (*n* = 31) and symptomatic carotid stenosis with neurological events within 6 months before the operation (*n* = 30). Preoperative hemodynamic instability requiring emergency interventions (IABP, ECLS) and patients with preoperatively elevated cardiac enzymes led to the exclusion from the analysis (*n* = 39). Ultimately, 106 patients with CEA + CABG were included in the analysis (CEA group).

Study parameters {#Sec7}
----------------

The demographic data and important risk factors for perioperative morbidity and mortality were compared between the study groups: gender, age, symptomatic carotid stenosis, ejection fraction, hypertension, renal insufficiency requiring dialysis, nicotine abuse, dyslipoproteinemia, and diabetes mellitus. Indicators of perioperative morbidity and mortality were the following: in-hospital mortality, in-hospital ipsilateral stroke, in-hospital ipsilateral TIA, any ipsilateral neurological event (stroke+TIA), carotid-related mortality, and the length of the intensive care unit/ intermediate care (ICU/IMC) stay.

Postoperative myocardial infarction was defined as the increase of creatine kinase levels (\> 800 U/l) with a concurrent significant CK-MB increase and the ST-segment elevation in the ECG \[[@CR11]\]. The severity of postoperative stroke was assessed with the NIHSS score in the acute phase and the modified Rankin scale (mRS) at discharge \[[@CR11]\].

Statistical analysis {#Sec8}
--------------------

The SPSS 23 software package (IBM Corporation, Somer, NY, USA) was used to perform the statistical analysis. Normality testing was assessed with the Kolmogorow-Smirnow test. Normal data were further analyzed with the two-tailed t-tests and categorical variables were processed by Fisher's exact test. Numerical and categorical variables are presented as the mean (±standard error) and percentages, respectively. *P* values \< 0.05 were considered significant.

Results {#Sec9}
=======

Overall 174 patients with an asymptomatic carotid artery stenosis ≥60% were referred to CABG procedure in our institution and included in the study. In the CEA group (*n* = 106), the carotid revascularization was performed as staged (*n* = 44) or synchronous (*n* = 62) procedure. In the no-CEA group, 68 individuals with a stenosis grade ≥ 60% were referred to CABG without carotid revascularization and served as a control group.

Demographic data {#Sec10}
----------------

Both study groups were comparable in terms of their demographic data and risk factors (Table [1](#Tab1){ref-type="table"}.). Male individuals were treated more often in both study groups, whereas the percentage of treated women was higher in the CEA group (CEA: 34/106 (32%); No-CEA 10/68 (14%); *p* = 0.0121; Table [1](#Tab1){ref-type="table"}.). Patients from the no-CEA group had more often dyslipoproteinemia (CEA: 37/106 (35%); No-CEA 35/68 (51%); *p* = 0.0401; Table [1](#Tab1){ref-type="table"}.). The mean carotid stenosis grade was significantly higher in the CEA group (CEA: 83% (±1); No-CEA 71% (±1) *p* \< 0.0001; Table [1](#Tab1){ref-type="table"}.). Table 1Demographic and operative parameters of the CEA and no-CEA study groupsCharacteristicCEA^**1**^No-CEApFemale sex34 (32%)10 (14%)0.0121\*Age (years)71 (±1)71 (±1)0.7101Diabetes mellitus46 (43%)31 (46%)0.8758Dyslipoproteinemia37 (35%)35 (51%)0.0401\*Arterial hypertension15 (14%)11 (16%)0.8280Nicotine abuseCurrent smoker7 (7%)8 (12%)0.0963 Prior smoker23 (22%)22 (32%)No smoker76 (72%)38 (56%)History of stroke16 (15%)10 (15%)0.9441Peripheral vascular disease19 (18%)17 (25%)0.3376Preoperative dialysis3 (3%)1 (1%)1.0Ejection fraction (%)51 (±1)50 (±2)0.4129Grade of carotid stenosis (%)83 (±1)71 (±1)\< 0.0001\*Preoperative patient status elective81 (76%)46 (68%)0.2037 urgent25 (24%)22 (32%) OPCAB18 (17%)15 (22%)0.4324Ordinal parameters are reported as percentage n (%). Continuous variables are presented as means (±standard error)^1^CEA carotid endarterectomy\*statistically significant

Outcome {#Sec11}
-------

The overall stroke rate was 3%, whereby strokes were not observed in the CEA group. The incidence of ipsilateral stroke was 7% in the no-CEA group (CEA: 0/106 (0%); No-CEA 5/68 (7%) *p* = 0.0083; Table [2](#Tab2){ref-type="table"}.). TIA occurred in one patient from the no-CEA group, which resulted in a total neurological event rate of 9% in this group (*p* = 0.0019). Patients with stroke had an ipsilateral carotid stenosis grade between 60 and 90%: 1 patient with a 60--69% stenosis (1/15; 7%), 2 patients with a 70--79% stenosis (2/40; 5%) and 2 patients with a stenosis ≥80% (2/13; 15%; *p* = 0.4569; Table [3](#Tab3){ref-type="table"}.). Symptom onset was after extubation in 3 out of 5 patients. The initial NIHSS score range was between 5 and 20 points (Table [3](#Tab3){ref-type="table"}.). An initial NIHSS score \> 10 was associated with a severe neurological deficit at discharge (mRS; Table [3](#Tab3){ref-type="table"}.). Two patients with postoperative strokes were treated urgently: one patient with carotid artery stenting, the second with a CEA (Table [3](#Tab3){ref-type="table"}.). The remaining patients were treated conservatively. Urgent cardiac operation (*p* = 0.7201) and the history of stroke (*p* = 0.7476) were not associated with a higher stroke incidence. Table 2Postoperative outcomes of the CEA and no-CEA study groupsPostoperative outcomeCEA^**1**^No-CEApIn-hospital mortality2 (1.9%)0 (0%)0.5211In-hospital stroke0 (0%)5 (7.4%)0.0083\*In-hospital TIA0 (0%)1 (1%)0.2105Any neurological event06 (9%)0.0019\*Myocardial infarction1 (1%)1 (1%)1.0IMC^2^/ICU^3^ stay7 (±1)9 (±1)0.1542Resternotomy5 (5%)5 (7%)0.5153Dysphagia5 (5%)8 (12%)0.1367Nerve injuries2 (2%)1 (1%)1.0Delirium14 (13%)14 (21%)0.2106Atrial fibrillation20 (19%)19 (28%)0.1931Ordinal parameters are reported as percentage n (%). Continuous variables are presented as means (±standard error)^1^CEA carotid endarterectomy^2^IMC intermediate care^3^ICU intensive care unit\*statistically significantTable 3Overview of patients with strokeNo.Stenosis gradeAtrial fibrillationSymptom onset\
(days after extubation)Initial NIHSS^1^\
scoreTherapymRS^2^ score at dis-charge160%No05conservative0270%No020conservative5380%No37CAS^3^2490%No28CEA^4^0570%, exulcerated plaqueNo014conservative4^1^NIHSS National Institute of Health Stroke Scale^2^mRS modified Rankin Score^3^CAS carotid artery stenting^4^CEA carotid endarterectomy

Overall mortality was 1% and it was not related to carotid stenosis or CEA: one patient died from a postoperative low cardiac output syndrome, the other patient from sepsis. There was no relevant difference in terms of mortality (CEA: 2/106 (2%); No-CEA 0/68 (0%) *p* = 0.5211; Table [2](#Tab2){ref-type="table"}.) and myocardial infarction (CEA: 1/106 (1%); No-CEA 1/68 (1%) *p* = 1.0; Table [2](#Tab2){ref-type="table"}.) between the groups. Intergroup differences for the incidence of postoperative hematoma, IMC/ICU stay, resternotomy, dysphagia, nerve injuries, delirium, and atrial fibrillation were not significant.

In the subgroup analysis of patients operated with a simultaneous or staged approach, the mortality was comparable (*simultaneous*: 1/62 (1%); *staged:* 1/44 (1%) *p* = 1.0; Table [4](#Tab4){ref-type="table"}.). The other predictors of poor postoperative outcome were comparable and not statistically significant. Particularly, the myocardial infarction was only observed after the simultaneous approach (*simultaneous*: 1/62 (2%); *staged:* 0/44 (0%) *p* = 1.0; Table [4](#Tab4){ref-type="table"}.). No patient from the staged subgroup had a myocardial infarction or required urgent cardiac surgery during the interstage phase (time between carotid and cardiac surgery). Among all patients assigned to the staged group, carotid and cardiac surgery were accomplished during the same hospital stay. Table 4Postoperative outcomes within the staged CEA and simultaneous CEA subgroupsPostoperative outcomeStaged CEA^**1**^Simultaneous CEApIn-hospital mortality1 (2%)1 (2%)1.0In-hospital stroke0 (0%)0 (0%)--Perioperative myocardial infarction0 (0%)1 (2%)1.0Revision/neck haematoma0 (0%)1 (2%)1.0IMC^2^/ICU^3^ stay9 (±2)5 (±1)0.4233Resternotomy3 (7%)2 (3%)0.6470Dysphagia2 (5%)3 (5%)1.0Nerve injuries0 (0%)2 (3%)0.5098Delirium5 (11%)9 (15%)0.7742Atrial fibrillation7 (16%)13 (21%)0.6179Ordinal parameters are reported as percentage n (%). Continuous variables are presented as means (±standard error)^1^CEA carotid endarterectomy^2^IMC intermediate care^3^ICU intensive care unit

Discussion {#Sec12}
==========

The most important findings of this study can be summarized as follows: (i)The treatment of the asymptomatic carotid artery stenosis ≥60% before CABG reduced the incidence of postoperative stroke after CABG in a small retrospective single-center cohort(ii)Staged approach with CEA in local anesthesia and selective shunting versus simultaneous approach with CEA + CABG in general anesthesia and routine shunting, showed comparable safety prior to CABG.(iii)Regarding the staged approach, the period between CEA and CABG did not bear an increased risk of cardiac complications, if both operations were performed during the same hospital stay.

Study design {#Sec13}
------------

Previously, different cut-off stenosis grade values for the treatment of asymptomatic carotid stenosis before CABG were reported and different approaches regarding the timing of the CEA prior to CABG were described \[[@CR6], [@CR7], [@CR12]\].

The cut-off value (≥60%) used in our study was derived from the national and international guidelines for the treatment of isolated carotid stenosis, which refer to ACAS and ACST-1 trials, and recommend the treatment of an asymptomatic 60--99% stenosis \[[@CR9], [@CR10], [@CR13], [@CR14]\]. Thus, in comparison to the prospective studies evaluating the risk and benefit of CEA before CABG the cut-off value in this study was lower (CABACS: 80%; Illuminati et al. 70%) \[[@CR6], [@CR15]\].

Our retrospective single-center study aimed to report the in-hospital outcomes of patients with unilateral asymptomatic carotid stenosis who were treated either with CEA + CABG or isolated CABG. The use of synchronous and staged CEA approach in our center in the past and the treatment of a considerable number of patients with isolated CABG in the presence of an untreated unilateral carotid stenosis, who served as a control group (no-CEA), enabled the performance of our study. Thus, the comparison of CEA and no-CEA patients was performed and a subgroup analysis of patients with two different carotid revascularization strategies was feasible. Currently, the evidence for the treatment of asymptomatic carotid stenosis prior to CABG is still limited. The AHA guidelines promote CEA before cardiac surgery in unilateral symptomatic stenosis only in symptomatic patients \[[@CR7]\]. In contrast, Illuminati et al. showed the superiority of the CEA over conservative asymptomatic carotid stenosis (≥70%) treatment before cardiac surgery regarding stroke prevention \[[@CR6]\]. However, the recent ESC/EACTS guidelines do not recommend the "routine prophylactic carotid revascularization" before CABG (Level of Evidence III, C) although CEA is recommended in case of "one or more characteristics, that may be associated with an increased risk of stroke" (Level of Evidence IIb, C) \[[@CR16]\]. The recent multicenter CABACS trial recruited 129 asymptomatic patients with a stenosis grade ≥ 80% and found no benefit of simultaneous CEA \[[@CR15]\]. However, the study did not reach the prespecified sample size and was stopped due to insufficient recruitment.

Stroke {#Sec14}
------

The occurrence of stroke after CABG is multifactorial. Embolic complications including air embolism, thromboembolism, and atheroembolism from the aorta are regarded as the predominant etiological factors for stroke during open heart surgery \[[@CR17]\]. Furthermore, the postoperative atrial fibrillation is related to stroke in 5 to 37% of stroke cases after CABG \[[@CR18], [@CR19]\].

In the presence of a carotid artery stenosis, hemodynamic instability may lead to a carotid-associated hemodynamic stroke during CABG. Illuminati et al. showed the benefit of CEA prior to CABG in their randomized prospective study \[[@CR6]\]. The stroke rate in the CEA group was 1.0%, compared to 8.8% in the group without carotid revascularization. The majority (84%) of their CEA group underwent simultaneous CEA + CABG. Therefore, the difference between the simultaneous and staged procedures could not be well assessed due to the small number of patients treated with the staged approach. Gopaldas et al. showed in a meta-analysis a comparable rate of postoperative stroke in the staged and synchronous CEA groups \[[@CR12]\].

In our study, strokes occurred only in the no-CEA group with a stroke rate of 7.4% which is comparable to the findings by Illuminati et al. This supports the idea of stroke risk reduction in patients with asymptomatic carotid stenosis prior to CABG. The percentage of staged CEA in our analysis amounted to 42% and both CEA subgroups (synchronous and staged) showed equivalent capacity to reduce stroke risk before CABG.

Myocardial infarction {#Sec15}
---------------------

When compared to the studies including patients who underwent CEA and cardiac surgery, the overall rate of myocardial infarction in our study was lower (1.9%), which may be explained by the exclusion of critically ill patients with elevated cardiac enzymes before admission to our center. The interstage phase between the CEA and CABG surgery was previously reported as a vulnerable period for myocardial infarction. Thus, a meta-analysis by Naylor et al. reported the incidence of myocardial infarction of 3.6% for the simultaneously operated group and 6.5% for the staged group \[[@CR20]\]. The higher risk of cardiac complications in the staged group was also reported by Gopaldas et al. and other authors \[[@CR12], [@CR21]--[@CR24]\]. Shishebor et al. reported that cardiac events in the interstage phase promote mortality after cardiac surgery \[[@CR21]\]. Myocardial infarction in the interstage phase was not observed in our study population. This may be related to our staged strategy, in which the completion of both surgical procedures during one hospital stay was aimed. The interstage phase was kept short (median: 4 days) to prevent the occurrence of cardiac complications in an out-of-hospital setting. Many previously published reports do not specify their interstage time interval. Reported intervals vary from 1.8 to 52 days \[[@CR25], [@CR26]\]. Nabagiez et al. promoted earlier cardiac surgery (within 1.8 days) and showed a low cardiac complication rate comparable to our results.

Limitations {#Sec16}
-----------

The present study is based on retrospective data and represents a single-center experience with low power: all information was assessed from the data available in the medical records. The main limitation of any study reporting the neurological outcome after CABG is the multifactorial nature of stroke after CABG: embolic strokes are more frequent than carotid-associated strokes, which may bias the results of the study. Furthermore, the significantly lower stenosis grade in the control group may underestimate the stroke risk in comparison to the CEA group.

Conclusions {#Sec17}
===========

CEA may have the potential to reduce the occurrence of perioperative strokes in patients with unilateral asymptomatic carotid stenosis undergoing CABG. The neurological outcomes of patients with a staged or synchronous approach were comparable. The staged procedure allows for optimal neurological monitoring during the CEA in local anesthesia, without increasing the risk of cardiac complications in the interstage phase. However, a prospective three-armed trial is necessary to compare the outcome of CABG patients with asymptomatic stenosis without CEA, staged, or simultaneous CEA approach.
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